Letizia Gianoncelli

Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial

Giovanni Luca Ceresoli, Joachim G.J.V. Aerts, Rafał Dziadziuszko et al. · The Lancet Oncology · 2019 · 153 citations

Single-arm Phase 2, Malignant Disease, Medicine +6

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

Giovanni Luca Ceresoli, Paolo Andrea Zucali, Fabio De Vincenzo et al. · Lung Cancer · 2011 · 139 citations

Pemetrexed-based Chemotherapy, Surgical Oncology, Medicine +7

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

Giovanni Luca Ceresoli, Paolo Andrea Zucali, Manlio Mencoboni et al. · British Journal of Cancer · 2013 · 105 citations · Full text

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

Paolo Andrea Zucali, Elisa Giovannetti, Annarita Destro et al. · Clinical Cancer Research · 2011 · 100 citations

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial

Carmine Pinto, Paolo Andrea Zucali, Maria Pagano et al. · The Lancet Oncology · 2021 · 98 citations

Second-line Treatment, Oncology, Malignant Pleural Mesothelioma +5